Бегущая строка

SIBN $24.70 6.0541%
SOI.PA $127.10 -4.6869%
ALGIL.PA $25.05 -2.5292%
1110.HK $0.77 8.4507%
VTRU $16.60 8.3225%
STLA $16.16 -0.8287%
BNKD $16.26 2.9766%
MEOA $11.13 -0.3581%
OIIL $43.00 0%
ACT.L $0.83 -10.8108%
0E9V.L $74.46 -4.7756%
1245.HK $0.29 3.5714%
DNN $1.09 -1.7387%
SNV $25.67 0.1561%
0P0001C5T8.L $10 219.20 0.2551%
TUEM $0.48 0%
XHS $88.37 -0.8462%
0092.HK $0.07 7.9365%
ARIX.L $106.50 1.4286%
IEA $13.72 0%
CEV $9.99 -0.1988%
0LID.L $27.50 -0.5493%
SXQG $22.62 0.5038%
MP $21.17 -2.5322%
KO $63.96 0.1488%
EQWL $76.37 -0.7782%
CLAS $10.17 0%
0JSP.L $33.66 0.9295%
XSER.L $9 886.00 0%
APT $3.89 -0.5115%
IEDY.L $13.79 -0.2532%
MMS.L $287.28 -1.1782%
IDRA $0.43 0%
AGT.L $189.60 -0.3155%
KOKU $73.70 0%
HERAW $0.00 0%
LLIS3.SA $1.73 0%
AGFS $3.00 0%
URE $56.02 0.2588%
0288.HK $4.21 -1.1737%
MCB.L $31.85 2.2472%
ET $12.29 -0.4457%
MMT.PA $13.17 -1.643%
XLRN $178.75 0%
FTF.L $60.50 0%
DLE.IR $0.58 1.7544%
1193.HK $28.20 -2.7586%
GBLIL $25.54 0%
LITM $2.68 1.9011%
PRU $78.14 -2.9441%
PZC $7.75 -1.2739%
ILCB $56.29 -0.6881%
PATH.L $0.27 0%
GLCB.L $33.67 -0.0594%
RITA $19.21 0.0802%
VIG $154.49 -0.4639%
49GP.L $96.50 0%
CHAD $19.39 0%
9988.HK $84.65 2.4198%
OFG $23.17 -1.5325%
QSR $72.53 -0.4256%
VGLT $64.78 -0.4457%
FORE $9.48 0%
STSA $1.06 -0.9346%
KLDO $0.00 19900%
ELLO $14.80 0.2031%
PARA $14.98 -2.568%
BCHN.L $59.44 -2.4454%
ALVGO.PA $3.55 1.1396%
PID.PA $29.20 0%
T14.SI $2.23 2.2936%
TGR.L $35.00 -2.2346%
0RG5.L $81.42 -1.1573%
GTYH $6.30 0%
KCGI $10.48 0%
NXGL $1.56 6.8493%
ROVR $4.66 -2%
MACP.L $1.88 0%
ALLGO.PA $1.30 1.5686%
0JZT.L $7.93 0.8904%
USNA $65.56 0.2983%
AXON $201.01 -1.7522%
QDIV.L $40.52 0.1258%
FLXG.L $26.82 -6.69798%
BSJS $20.98 -0.2397%
6999.HK $0.27 0%
JUNS $0.00 0%
TASA4.SA $15.94 -0.4994%
MSPR $1.60 46.789%
FTXN $25.13 -0.1609%
FHN-PD $18.41 -0.1356%
GFAIW $0.29 7.037%
XT0D.L $54.96 0.0637%
SOND $0.31 -22.3235%
ONB $12.09 -0.124%
AMKR $21.13 -1.2155%
CMRA $0.60 -14.0694%
RENEW $0.16 0%
EEMD $17.65 -1.8329%
HPAE.L $17.49 0%

Хлебные крошки

Акции внутренные

Лого

Altimmune, Inc. ALT

$5.04

-$0.27 (-5.44%)
На 18:01, 12 мая 2023

+519.05%

Потенциал через год

Ранг: 3

Ранг - это оценка кредитоспособности корпорации.

Ключевые показатели

  • Marketcap

    257235858.00000000

  • week52high

    23.49

  • week52low

    3.82

  • Revenue

    -68000

  • P/E TTM

    -3

  • Beta

    -0.09550100

  • EPS

    -1.83000000

  • Last Dividend

    1746.01000000

  • Next Earnings Date

    10 мая 2023 г. в 12:30

Описание компании

Altimmune, Inc., a clinical stage biopharmaceutical company, focuses on developing treatments for obesity and liver diseases. The company's lead product candidate, pemvidutide (proposed INN, formerly known as ALT-801), is a GLP-1/glucagon dual receptor agonist that is in Phase 1b trial for the treatment of obesity and non-alcoholic steatohepatitis. It is also developing HepTcell, an immunotherapeutic product candidate, which is in Phase 2 clinical trial for patients chronically infected with the hepatitis B virus. The company was formerly known as Vaxin Inc. and changed its name to Altimmune, Inc. in September 2015. Altimmune, Inc. was founded in 1997 is headquartered in Gaithersburg, Maryland.

Рекомендации
аналитиков

Рекомендации аналитиков — понятие, что это такое и как.

Рекомендации аналитиков

Grading company New grade Previous grade Recommendation date
Jefferies Buy Buy 31 авг 2022 г.
HC Wainwright & Co. Buy Buy 17 авг 2022 г.
B. Riley Securities Buy Buy 12 авг 2022 г.
Piper Sandler Overweight Overweight 18 мая 2022 г.
JMP Securities Market Outperform Market Outperform 30 июн 2021 г.
Guggenheim Buy Buy 16 сент 2022 г.
JMP Securities Market Outperform Market Outperform 11 ноя 2022 г.
Goldman Sachs Buy 01 дек 2022 г.
HC Wainwright & Co. Buy 20 янв 2023 г.
Evercore ISI Group Outperform Outperform 18 янв 2023 г.

Свежие комментарии

Свежие комментарии

Оставьте свой голос

Оставьте свой голос

Анонимное голосование

Будет ли рост российского рынка к концу года?

  • Да

    87%
  • Нет

    12%

Проголосовал 8 человек

Новостная лента
компании

Новостная лента

  • Изображение

    Altimmune to Participate at Two Upcoming Investor Conferences

    GlobeNewsWire

    08 мая 2023 г. в 07:30

    GAITHERSBURG, Md., May 08, 2023 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical company, today announced that members of the Company's management team will participate and be available for 1x1 meetings at the following investor conferences:

  • Изображение

    Altimmune to Report First Quarter 2023 Financial Results and Provide Business Update on May 11, 2023

    GlobeNewsWire

    04 мая 2023 г. в 07:30

    GAITHERSBURG, Md., May 04, 2023 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical company, today announced that it will report its first quarter 2023 financial results on Thursday, May 11, 2023 and will provide a business update.

  • Изображение

    The 3 Most Promising Biotech Innovations in 2023 and the Stocks to Buy

    InvestorPlace

    28 апр 2023 г. в 06:26

    The biotech sector is up 4.76% so far in 2023. This continues the nice run that biotech stocks had in 2022.

  • Изображение

    Top Penny Stocks To Buy Now? 10 To Watch Under $5

    PennyStocks

    13 апр 2023 г. в 11:27

    10 Penny stocks under $5 to watch right now The post Top Penny Stocks To Buy Now? 10 To Watch Under $5 appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

  • Изображение

    7 Top Penny Stocks Under $5; Time To Buy Now?

    PennyStocks

    29 мар 2023 г. в 11:28

    Penny stocks to watch before next week. The post 7 Top Penny Stocks Under $5; Time To Buy Now?



Insider Summary

Insider Summary

Reporting Name Acquistion/Disposition Owned Transacted Transaction Date
Garg Vipin K D 33090 16546 01 февр 2023 г.
Garg Vipin K D 238601 7658 01 февр 2023 г.
Garg Vipin K A 246259 16546 01 февр 2023 г.
Harris Matthew Scott D 12332 6166 01 февр 2023 г.
Harris Matthew Scott D 17900 2183 01 февр 2023 г.
Harris Matthew Scott A 20083 6166 01 февр 2023 г.
Roberts M Scot D 12332 6166 01 февр 2023 г.
Roberts M Scot D 14456 2183 01 февр 2023 г.
Roberts M Scot A 16639 6166 01 февр 2023 г.
Eisenstadt Richard I A 12010 1172 31 янв 2023 г.